Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Allenbach

Showing results (11-20 of 182) with videos related to

Pageof 19
Sort By:
Nature Reviews. Rheumatology|October 23, 2020
Immune-mediated necrotizing myopathy: clinical features and pathogenesisYves Allenbach, Olivier Benveniste, Werner Stenzel, et al.
Gastroenterology|November 30, 2024
Think Beyond the Typical!Bertha Maria Nassani, Armelle Bardier Dupas, Yves Allenbach
Neuromuscular Disorders : NMD|December 4, 2019
239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018Andrew L Mammen, Yves Allenbach, Werner Stenzel, et al.
Current Rheumatology Reports|August 4, 2018
Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing MyopathiesLeandro Ladislau, Louiza Arouche-Delaperche, Yves Allenbach, et al.
Brain : a Journal of Neurology|October 19, 2018
Reply: A child with severe juvenile dermatomyositis treated with ruxolitinibYves Allenbach, Ségolène Toquet, Océane Landon-Cardinal, et al.
Neuromuscular Disorders : NMD|December 10, 2017
224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016Yves Allenbach, Andrew L Mammen, Olivier Benveniste, et al.
Best Practice & Research. Clinical Rheumatology|July 1, 2022
Possible future avenues for myositis therapeutics: DM, IMNM and IBMCaoilfhionn M Connolly, Lotta Plomp, Julie J Paik, et al.
Autoimmunity Reviews|January 15, 2019
Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathyCéline Anquetil, Olivier Boyer, Nadège Wesner, et al.
Journal of Translational Autoimmunity|March 4, 2022
Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-upCarolien Bonroy, Yves Piette, Yves Allenbach, et al.
Plos One|November 23, 2013
Beneficial role of rapamycin in experimental autoimmune myositisNicolas Prevel, Yves Allenbach, David Klatzmann, et al.
Pageof 19

Showing results (11-20 of 182) with videos related to

Sort By:
Pageof 19
Nature Reviews. Rheumatology|October 23, 2020
Immune-mediated necrotizing myopathy: clinical features and pathogenesisYves Allenbach, Olivier Benveniste, Werner Stenzel, et al.
Gastroenterology|November 30, 2024
Think Beyond the Typical!Bertha Maria Nassani, Armelle Bardier Dupas, Yves Allenbach
Neuromuscular Disorders : NMD|December 4, 2019
239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018Andrew L Mammen, Yves Allenbach, Werner Stenzel, et al.
Current Rheumatology Reports|August 4, 2018
Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing MyopathiesLeandro Ladislau, Louiza Arouche-Delaperche, Yves Allenbach, et al.
Brain : a Journal of Neurology|October 19, 2018
Reply: A child with severe juvenile dermatomyositis treated with ruxolitinibYves Allenbach, Ségolène Toquet, Océane Landon-Cardinal, et al.
Neuromuscular Disorders : NMD|December 10, 2017
224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016Yves Allenbach, Andrew L Mammen, Olivier Benveniste, et al.
Best Practice & Research. Clinical Rheumatology|July 1, 2022
Possible future avenues for myositis therapeutics: DM, IMNM and IBMCaoilfhionn M Connolly, Lotta Plomp, Julie J Paik, et al.
Autoimmunity Reviews|January 15, 2019
Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathyCéline Anquetil, Olivier Boyer, Nadège Wesner, et al.
Journal of Translational Autoimmunity|March 4, 2022
Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-upCarolien Bonroy, Yves Piette, Yves Allenbach, et al.
Plos One|November 23, 2013
Beneficial role of rapamycin in experimental autoimmune myositisNicolas Prevel, Yves Allenbach, David Klatzmann, et al.
Pageof 19